Skip to main content

Lexaria Bioscience Corp.

LEXX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001348362

No open-market purchases or sales by Lexaria Bioscience Corp. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $920.0K in total; no superinvestor holds it.

Superinvestors holding LEXX, Q2 2026

See all superinvestors

No superinvestor reported holding LEXX in Q2 2026.